Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal ropivacaine with dexmedetomidine dose comparison in cesarean section
ChiCTR1800014454Phase 4Not yet recruiting
- Sponsor
- The 2nd Affiliated Hospital of Harbin Medical University
- Start
- Feb 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ropivacaine and dexmedetomidine in caesarean delivery (C-section) (3 arms), sponsored by The 2nd Affiliated Hospital of Harbin Medical University. Primary endpoints: Sensory block plane, Visual analogue scale score and 3 more. Planned start Feb 2018; status: not yet recruiting.
02
Drugs
ropivacainedexmedetomidine
03
Conditions
caesarean delivery (C-section)
Beyond the preview
Go deeper on ChiCTR1800014454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800014454.